Patent · US Active

Modified cells and methods of therapy

US11147837B2 · kind B2 · utility

5Cited by

54References

49Claims

0Family size

Assignees

Regents of the University of Minnesota · US
INTIMA BIOSCIENCE, INC. · US
The United States of America, as represented by the Secretary, Department of Health and Human Services · US

Inventors

Branden Moriarity · Shoreview, US
Beau Webber · Coon Rapids, US
Modassir Choudhry · New York, US
R. Scott McIvor · St. Louis Park, US
David Largaespada · Mounds View, US
Steven A. Rosenberg · Potomac, US
Douglas C. Palmer · North Bethesda, US
Nicholas P. Restifo · Chevy Chase Section Five, US

Key dates

Filing date	Sep 2, 2016
Grant date	Oct 19, 2021
Priority date	—
Expiry date	Sep 2, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2510/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.